Published: 2017-09-13 08:26:08 CEST
Olainfarm
Other information disclosed according to the rules of the Exchange

Recording of the Second Quarter 2017 Investor Conference Webinar

On September 11 AS „Olainfarm” organized its Investor Conference Online Webinar. During the webinar the member of the management board of AS „Olainfarm” Salvis Lapiņš analyzed the financial results of second quarter 2017 and informed about the other recent activities within the company.

Olaine, 2017-09-13 08:26 CEST (GLOBE NEWSWIRE) -- The recorded AS “Olainfarm” webinar is available online: ej.uz/OLF_Q22017_rec, and the presentation, demonstrated during the webinar, is available in the previously published company’s announcement: ej.uz/OLF_Q22017_EN.
 

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
 

         Information prepared by:
         
         Salvis Lapins
         JSC Olainfarm
         Member of the Management Board
         Rupnicu iela 5, Olaine, Latvia, LV 2114
         
         Phone: +371 6 7013 717
         Fax: +371 6 7013 777
         E-mail: Salvis.Lapins@olainfarm.lv